TREACE MEDICAL CONCEPTS INC (TMCI) Stock Balance Sheet
USA - NASDAQ:TMCI - US89455T1097 - Common Stock
6 USD
-0.3 (-4.76%)
6 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 5.48M | 5.36M | 9.82M | 3.30M | N/A | |||
| Cash Equivalents | 2.57M | 6.00M | 3.16M | 16.20M | 105.80M | |||
| Marketable Securities | 61.24M | 64.33M | 110.22M | 61.80M | N/A | |||
| Receivables | 30.33M | 40.80M | 38.06M | 29.20M | 18.60M | |||
| Inventories | 42.40M | 39.26M | 29.25M | 19.30M | 10.60M | |||
| Other Current Assets | 5.58M | 5.67M | 7.85M | 3.60M | 3.00M | |||
| Total Current Assets | 147.60M | 161.40M | 198.36M | 133.40M | 138.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 37.75M | 34.40M | 31.56M | 25.50M | 2.80M | |||
| Goodwill | 12.81M | 12.81M | 12.81M | N/A | N/A | |||
| Intangibles | 7.60M | 8.07M | 9.03M | N/A | N/A | |||
| Other Non-Current Assets | 676.00K | 407.00K | 146.00K | 100.00K | N/A | |||
| Total Non-Current Assets | 58.84M | 55.69M | 53.55M | 25.60M | 2.80M | |||
| TOTAL ASSETS | 206.44M | 217.09M | 251.91M | 159.00M | 140.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 1.11M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 20.67M | 24.31M | 30.17M | 21.60M | 14.20M | |||
| Accounts Payable | 19.96M | 10.52M | 11.84M | 8.70M | 4.10M | |||
| Other Current Liabilities | 154.00K | 97.00K | 3.03M | N/A | N/A | |||
| Total Current Liabilities | 41.90M | 34.92M | 45.03M | 30.20M | 18.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 53.45M | 53.31M | 53.01M | 52.70M | 29.40M | |||
| Other Non-Current Liabilities | 13.47M | 15.97M | 15.93M | 15.50M | 200.00K | |||
| Total Non-Current Liabilities | 66.93M | 69.28M | 68.94M | 68.30M | 29.50M | |||
| TOTAL LIABILITIES | 108.83M | 104.20M | 113.97M | 98.50M | 47.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -223.31M | -189.99M | -134.25M | -84.70M | -41.90M | |||
| Additional Paid In Capital | 321.51M | 303.00M | 271.97M | 145.20M | 134.90M | |||
| Common Shares | 63.00K | 62.00K | 62.00K | 100.00K | 0.00 | |||
| Treasury Stock | -696.00K | -281.00K | -13.00K | N/A | N/A | |||
| Other Shareholders' Equity | 50.00K | 97.00K | 163.00K | 0.00 | N/A | |||
| Shares Outstanding | 63.04M | 62.39M | 61.75M | 55.60M | 54.20M | |||
| Tangible Book Value per Share | 1.22 | 1.47 | 1.88 | 1.09 | 1.72 | |||
| Total Shareholders' Equity | 97.61M | 112.89M | 137.94M | 60.50M | 93.10M | |||
| TOTAL LIABILITIES AND EQUITY | 206.44M | 217.09M | 251.91M | 159.00M | 140.80M | |||
| Statistics | ||||||||
| Debt/Equity | 0.56 | 0.47 | 0.38 | 0.87 | 0.32 | |||
| Current Ratio | 3.52 | 4.62 | 4.40 | 4.42 | 7.58 | |||
| Return On Assets (ROA) | -23.82% | -25.68% | -19.66% | -26.92% | -14.70% | |||
| Return On Equity (ROE) | -50.38% | -49.38% | -35.91% | -70.74% | -22.23% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21